<DOC>
	<DOC>NCT00001254</DOC>
	<brief_summary>This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.</brief_summary>
	<brief_title>Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome</brief_title>
	<detailed_description>This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<criteria>INCLUSION CRITERIA: New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89DK0005). Only those patients that are being treated under the protocol entitled, "Medical Therapy of ZollingerEllison Syndrome" (protocol # 89DK0015) will be entered into this tumor localization and management protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 27, 2017</verification_date>
	<keyword>Islet Cell Tumors</keyword>
</DOC>